Penumbra ace68_catheter 26 July.jpg” />

US-based medical device company Penumbra has commercially introduced its thrombectomy device, the ACE 68 Reperfusion Catheter in the US.

The catheter is based on the latest technology to offer maximum aspiration power in an easy and safe way for extracting thrombus in acute ischemic stroke patients.

The device features a coil winding geometry along 16 transitions to promote an optimum tracking profile which is done through tortuosity characterising an acute ischemic stroke in patients.

It is designed to extract the clot quickly and effectively as a part of the Penumbra system.

Semmes-Murphey Neurologic & Spine Institute Department of Neurosurgery, UTHSC professor Adam Arthur said: “The ACE68 provides an opportunity to reverse strokes faster and with less expense.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“The larger lumen seems to allow better clot capture, which may reduce the need for adjunctive devices, simplify the procedure and reduce procedure cost important considerations as hospitals look to expand stroke services.”

The ACE68 Reperfusion Catheter is a part of the fully integrated Penumbra System used for revascularisation of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease after displaying of symptom within eight hours.

"The early reports from physicians on the performance of ACE68 confirm that this is the most impactful stroke product we have ever developed."

Penumbra chairman and chief executive officer Adam Elsesser said: "We designed the ACE68 with the intent to make real improvement on stroke procedure time, outcome and cost.

"The early reports from physicians on the performance of ACE68 confirm that this is the most impactful stroke product we have ever developed."

The Penumbra System is integrated with large, highly pliable and trackable Reperfusion Catheters that leverages on the full aspiration power of the Penumbra Pump MAX within an integrated, patented system to eliminate chances of the stroke-causing occlusion safely and effectively.

Image: The ACE6 8 Reperfusion Catheter. Photo: courtesy of Penumbra.